Pictet Asset Management Holding SA »

Tg Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $84M 3.6M 23.39
2024-03-31 $51M 3.3M 15.21

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
BlackRock
State Street Corporation
Soleus Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Deep Track Capital
Woodline Partners
Susquehanna International
Opaleye Management
Goldman Sachs Group
Bank of America Corporation
Nuveen Asset Management
Morgan Stanley

View all funds holding Tg Therapeutics